Ocular Therapeutix (OCUL) Work In Process (2014 - 2026)
Ocular Therapeutix (OCUL) posted Work In Process of $1.12 million for Q2 2026, down 35.3% from $1.74 million a year earlier and down 9.5% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Work In Process (2014 - 2026) Analysis & Trends
At the end of FY2025, Ocular Therapeutix's Work In Process came in at $1.72 million, up 15.6% from FY2024.
- Annual Work In Process has increased for seven consecutive years, with a five-year compound annual growth rate of 49.3% (FY2020 to FY2025).
- In prior years, Ocular Therapeutix's Work In Process was $1.49 million in FY2024 (+47.1%), $1.01 million in FY2023 (+12.6%), $899,000 in FY2022 (+48.6%) and $605,000 in FY2021 (+160.8%).
- The Q2 2026 figure stands as the lowest quarterly Work In Process since Q2 2024.
- On a year-over-year basis, Work In Process increased in five of the last eight quarters, with growth averaging 25.3%.
- The strongest year-over-year quarter for Work In Process in the past five years was Q3 2021, with growth of 650.7%; the weakest was Q2 2026, with a decline of 35.3%.
- According to Business Quant data, Work In Process for the three prior quarters was $1.24 million (Q1 2026), $1.72 million (Q4 2025) and $1.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 915,000.00 |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 947,000.00 |
| Jun 30, 2023 | 682,000.00 |
| Mar 31, 2023 | 773,000.00 |
| Dec 31, 2022 | 899,000.00 |
| Sep 30, 2022 | 885,000.00 |
| Jun 30, 2022 | 662,000.00 |
| Mar 31, 2022 | 567,000.00 |
| Dec 31, 2021 | 605,000.00 |
| Sep 30, 2021 | 563,000.00 |
API Access
Ocular Therapeutix Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();